These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8324904)

  • 1. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K; Moschese V; Broliden PA; Giaquinto C; Quinti I; Fenyö EM; Wahren B; Rossi P; Jondal M
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
    Vogel T; Kurth R; Norley S
    J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization.
    Ljunggren K; Chiodi F; Broliden PA; Albert J; Norkrans G; Hagberg L; Jondal M; Fenyö EM
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):629-38. PubMed ID: 2611043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study.
    Pugatch D; Sullivan JL; Pikora CA; Luzuriaga K
    J Infect Dis; 1997 Sep; 176(3):643-8. PubMed ID: 9291310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
    Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
    J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.
    Kumar S; Batra H; Singh S; Chawla H; Singh R; Katpara S; Hussain AW; Das BK; Lodha R; Kabra SK; Luthra K
    J Gen Virol; 2020 Dec; 101(12):1289-1299. PubMed ID: 32915123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.
    Tuyishime M; Garrido C; Jha S; Moeser M; Mielke D; LaBranche C; Montefiori D; Haynes BF; Joseph S; Margolis DM; Ferrari G
    J Clin Invest; 2020 Oct; 130(10):5157-5170. PubMed ID: 32584790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing infant antibody-dependent cellular cytotoxicity associates with reduced HIV-1 acquisition and lower morbidity.
    Thomas AS; Moreau Y; Jiang W; Isaac JE; Ewing A; White LF; Kourtis AP; Sagar M
    Cell Rep Med; 2021 Oct; 2(10):100412. PubMed ID: 34755132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
    Füst G; Tóth FD; Kiss J; Ujhelyi E; Nagy I; Bánhegyi D
    AIDS; 1994 May; 8(5):603-9. PubMed ID: 7914732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?
    Lee WS; Kent SJ
    Curr Opin HIV AIDS; 2018 Mar; 13(2):160-166. PubMed ID: 29194123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.
    Subbramanian RA; Xu J; Toma E; Morisset R; Cohen EA; Menezes J; Ahmad A
    J Clin Microbiol; 2002 Jun; 40(6):2141-6. PubMed ID: 12037078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.